Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS (Acquired Immune Deficiency Syndrome)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002184
What this trial is testing

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Who this might be right for
HIV Infections
Gilead Sciences 120
Not applicableUnknownNCT04788784
What this trial is testing

Patient-Reported Outcomes HIV BItherapy

Who this might be right for
HIV/AIDS and InfectionsPatient Preference
University Paris 7 - Denis Diderot 250
Not applicableEnded earlyNCT06045923
What this trial is testing

Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV

Who this might be right for
MonkeypoxHIV InfectionsAIDS
Centers for Disease Control and Prevention 100
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Early research (Phase 1)Study completedNCT05261191
What this trial is testing

MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy

Who this might be right for
Human Immunodeficiency Virus I InfectionImmunodeficiency Virus Type 1, HumanHuman Immunodeficiency Virus Type 1
MacroGenics 17
Early research (Phase 1)Study completedNCT03899480
What this trial is testing

Adoptive Transfer of Haploidentical NK Cells and N-803

Who this might be right for
HivHIV InfectionsImmune Deficiency
University of Minnesota 9
Not applicableStudy completedNCT03834779
What this trial is testing

HIV+ Substance Users Released From Jail

Who this might be right for
HIV/AIDSSubstance Use Disorders
University of Texas Southwestern Medical Center 31
Not applicableUnknownNCT05137210
What this trial is testing

Identifying Efficient Linkage Strategies for Men

Who this might be right for
Hiv
University of California, Los Angeles 569
Post-approval studies (Phase 4)Study completedNCT03250910
What this trial is testing

Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
National Taiwan University Hospital 228
Not applicableStudy completedNCT04417946
What this trial is testing

Peer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM)

Who this might be right for
Pre-Exposure ProphylaxisHivMen
Yale University 227
Not applicableStudy completedNCT02614027
What this trial is testing

Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances

Who this might be right for
LipodystrophyMetabolic Syndrome
Asociacion para el Estudio de las Enfermedades Infecciosas 276
Not applicableStudy completedNCT00661960
What this trial is testing

Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy

Who this might be right for
HIV InfectionsAIDS
University of California, Davis 25
Large-scale testing (Phase 3)Study completedNCT00002124
What this trial is testing

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Who this might be right for
HIV Infections
Pharmacia and Upjohn 1,250
Post-approval studies (Phase 4)Study completedNCT04166474
What this trial is testing

Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin

Who this might be right for
HivTuberculosis
Helen Reynolds 36
Post-approval studies (Phase 4)Ended earlyNCT00533390
What this trial is testing

Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg

Who this might be right for
TuberculosisHIV Infections
Oswaldo Cruz Foundation 130
Not applicableLooking for participantsNCT04653610
What this trial is testing

Sequential Analysis Before and After Treatment Initiation to Unravel the Role of Naturally Occurring Extracellular Vesicles in HIV Infection

Who this might be right for
Hiv
University Hospital, Ghent 105
Large-scale testing (Phase 3)Study completedNCT04618198
What this trial is testing

Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa

Who this might be right for
TuberculosisHIV I InfectionSepsis
University of Virginia 437
Testing effectiveness (Phase 2)UnknownNCT03103555
What this trial is testing

Treatment of Adult-Onset Immunodeficiency With Bortezomib

Who this might be right for
Adult-onset Immunodeficiency
Mahidol University 5
Not applicableStudy completedNCT00002293
What this trial is testing

Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes

Who this might be right for
Candidiasis, OralHIV Infections
Bristol-Myers Squibb
Post-approval studies (Phase 4)Enrolling By InvitationNCT07707778
What this trial is testing

Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV

Who this might be right for
Human Immunodeficiency Virus (HIV)Metabolic Dysfunction Associated Steatotic Liver DiseaseDyslipidaemia+3 more
National Taiwan University Clinical Trial Center 60
Next Page